Gross Profit: Revenues from operations less the associated costs.
Gossamer Bio, Inc. (GOSS) had Gross Profit of $13.29M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$13.29M |
|
$-48.22M |
|
-- |
|
|
Gross Profit |
$13.29M |
$62.41M |
|
$-49.11M |
|
$0.89M |
|
$-48.22M |
|
$-48.22M |
|
$-48.22M |
|
$-48.22M |
|
$-48.22M |
|
$-48.22M |
|
$-49.11M |
|
$-50.23M |
|
227.98M |
|
227.98M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$203.99M |
|
$0.07M |
|
$4.83M |
|
$208.82M |
|
$62.12M |
|
$198.26M |
|
$229.04M |
|
$291.15M |
|
$-82.33M |
|
$-82.33M |
|
$-82.33M |
|
231.31M |
|
| Cash Flow Statement Financials | |
$-122.95M |
|
$83.20M |
|
$2.47M |
|
$46.07M |
|
$8.93M |
|
$-37.14M |
|
$7.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.28 |
|
-- |
|
-- |
|
1.71 |
|
-2.41 |
|
100.00% |
|
-369.44% |
|
-369.44% |
|
-- |
|
-362.73% |
|
-362.73% |
|
$-123.03M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
1.44 |
|
62.57 |
|
58.57% |
|
58.57% |
|
-23.09% |
|
-41.60% |
|
$-0.36 |
|
$-0.54 |
|
$-0.54 |
|